<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1538973079464292&amp;ev=PageView&amp;noscript=1">
Facebook Twitter LinkedIn LinkedIn

Learn about the history of Lyme disease and ZEUS’s Borrelia MTTT™ algorithm that led to a paradigm shift in Lyme disease testing

Register HERE for an upcoming webinar “Paradigm Shift in Lyme Disease Testing”. Daniel Zweitzig, Director of Research & Development at ZEUS Scientific will provide information on the history and epidemiology of Lyme disease and will chronicle ZEUS’s 33-year journey of pioneering new Lyme diagnostics from the first FDA-cleared Lyme Serology product to the first and only FDA-cleared Borrelia Modified Two-Tiered Testing (MTTT™) algorithm. He will outline several publications that pointed ZEUS in the direction to validate a replacement of the Standard Two-Tiered Testing (STTT) algorithm. Be sure to make plans to hear Dan’s detailed explanation of the clinical studies conducted that demonstrated superior sensitivity to the STTT algorithm.  Find out how we can change the game together by detecting up to 30% more stage 1 and stage 2 Lyme disease. Join the discussion! October 29th at 10am EST